The authors examine the effectiveness of an excipient comprised of mannitol, polyvinyl acetate, and crospovidone using model actives loperamide hydrogen chloride and caffeine.
Karl Kolter
Advertisement
K. Kolter, PhD, is head of R&D for pharmaceutical excipients, BASF SE, G-EMP-MD-H201, Ludwigshafen, Germany, 67056, tel. + 49 621 6041664, fax; 49 621 6097370, karl.kolter@basf.com
Articles by Karl Kolter
Advertisement
Latest Updated Articles
Development of Orally Disintegrating Tablets Based on a New ExcipientPublished: November 2nd 2008 | Updated:
Advertisement
Advertisement
